- £56.72m
- £52.42m
- £4.00m
RCS - Creo Medical Group - UK & EU Commercial launch of SpydrBlade™ Flex
AnnouncementREG - Creo Medical Group - Appointment of Nominated Adviser and sole Broker
AnnouncementREG - Creo Medical Group - FY24 Trading Update
AnnouncementREG - Creo Medical Group - Completion of sale of 51% interest in subsidiary
AnnouncementRCS - Creo Medical Group - First Welsh adopter of Speedboat® technology
AnnouncementREG - Creo Medical Group - Total Voting Rights
AnnouncementREG - AIM - AIM Notice - 31/01/2025
AnnouncementREG - Creo Medical Group - Award of Shares under Share Incentive Plan
AnnouncementREG - Creo Medical Group - First robotic-guided lung ablation cases commence
AnnouncementREG - Creo Medical Group - Director/PDMR Shareholding
AnnouncementREG - Creo Medical Group - Total Voting Rights
AnnouncementREG - Creo Medical Group - Director/PDMR Shareholding
AnnouncementREG - Creo Medical Group - Director/PDMR Share Dealings
AnnouncementREG - AIM - AIM Notice - 21/10/2024
AnnouncementREG - Creo Medical Group - Result of General Meeting & TVR
AnnouncementREG - Creo Medical Group - Result of Retail Offer
AnnouncementREG - Creo Medical Group - Extension of Retail Offer Closing Date
AnnouncementREG - Creo Medical Group - Result of Placing
AnnouncementREG - Creo Medical Group - Half-year Report
Announcement